Hisamitsu Pharmaceutical Co., Inc. (TYO:4530)

TYO:4530 Balance Sheet

Financials in millions JPY. Fiscal year is March - February.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 31, 2025	Feb 28, 2025	Feb 29, 2024	Feb 28, 2023	Feb 28, 2022	Feb 28, 2021
Cash & Equivalents	104,107	114,518	112,459	122,154	129,290	114,254
Short-Term Investments	14,020	14,598	12,862	14,714	13,141	21,743
Cash & Short-Term Investments	118,127	129,116	125,321	136,868	142,431	135,997
Cash Growth	-3.71%	3.03%	-8.44%	-3.91%	4.73%	-4.18%
Receivables	47,089	46,879	42,983	39,753	38,112	39,203
Inventory	25,129	22,391	21,176	18,922	16,412	18,568
Other Current Assets	7,094	5,402	4,542	3,631	3,221	4,293
Total Current Assets	197,439	203,788	194,022	199,174	200,176	198,061
Property, Plant & Equipment	58,467	59,899	49,462	43,209	39,069	37,354
Long-Term Investments	60,168	71,494	76,813	69,244	61,133	62,220
Goodwill	1,256	1,294	1,444	-	-	-
Other Intangible Assets	4,605	4,680	5,387	946	1,326	1,178
Long-Term Deferred Tax Assets	-	1,911	1,649	1,342	1,153	1,047
Other Long-Term Assets	12,999	2	2	2	1	1
Total Assets	334,934	343,068	328,779	313,917	302,858	299,861
Accounts Payable	9,523	14,115	16,263	14,918	13,225	14,799
Accrued Expenses	510	2,213	1,831	1,340	1,363	1,350
Short-Term Debt	963	1,065	1,071	1,071	1,071	1,111
Current Portion of Leases	-	409	350	327	301	101
Current Income Taxes Payable	1,282	11,779	9,861	8,587	9,623	7,242
Other Current Liabilities	33,705	17,645	16,562	16,335	6,577	5,454
Total Current Liabilities	45,983	47,226	45,938	42,578	32,160	30,057
Long-Term Debt	1,683	1,694	76	147	219	296
Long-Term Leases	-	688	603	750	869	94
Long-Term Deferred Tax Liabilities	-	4,304	4,518	1,813	4,170	5,125
Other Long-Term Liabilities	6,563	1,932	1,967	1,815	2,339	2,553
Total Liabilities	62,004	63,663	61,700	55,511	47,973	46,053
Common Stock	8,473	8,473	8,473	8,473	8,473	8,473
Additional Paid-In Capital	2,359	2,361	2,361	2,361	2,356	2,352
Retained Earnings	257,144	257,881	242,578	235,569	236,192	233,376
Treasury Stock	-47,368	-47,550	-36,993	-27,196	-19,527	-11,495
Comprehensive Income & Other	49,765	55,659	48,455	37,157	25,674	19,592
Total Common Equity	270,373	276,824	264,874	256,364	253,168	252,298
Minority Interest	2,557	2,581	2,205	2,042	1,717	1,510
Shareholders' Equity	272,930	279,405	267,079	258,406	254,885	253,808
Total Liabilities & Equity	334,934	343,068	328,779	313,917	302,858	299,861
Total Debt	2,646	3,856	2,100	2,295	2,460	1,602
Net Cash (Debt)	115,481	125,260	123,221	134,573	139,971	134,395
Net Cash Growth	-4.99%	1.65%	-8.44%	-3.86%	4.15%	-4.11%
Net Cash Per Share	1581.77	1699.18	1600.21	1694.75	1722.30	1643.25
Filing Date Shares Outstanding	73.01	72.96	75.74	77.77	79.74	81.76
Total Common Shares Outstanding	73.01	72.96	75.74	77.74	79.74	81.73
Working Capital	151,456	156,562	148,084	156,596	168,016	168,004
Book Value Per Share	3703.35	3794.04	3497.00	3297.53	3175.01	3086.80
Tangible Book Value	264,512	270,850	258,043	255,418	251,842	251,120
Tangible Book Value Per Share	3623.07	3712.17	3406.82	3285.36	3158.38	3072.39

Updated Jan 9, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.